Eli Lilly and Company
LLY
$659.50
$20.073.14%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 22.23% | -5.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 22.23% | -5.94% | |||
| Cost of Revenue | 10.05% | -7.47% | |||
| Gross Profit | 24.81% | -5.61% | |||
| SG&A Expenses | 12.08% | 2.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.18% | -5.36% | |||
| Operating Income | 31.76% | -6.72% | |||
| Income Before Tax | 96.07% | -31.41% | |||
| Income Tax Expenses | 60.15% | 10.80% | |||
| Earnings from Continuing Operations | 105.14% | -37.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 105.14% | -37.43% | |||
| EBIT | 31.76% | -6.72% | |||
| EBITDA | 29.53% | -6.55% | |||
| EPS Basic | 105.33% | -37.12% | |||
| Normalized Basic EPS | 30.96% | -6.38% | |||
| EPS Diluted | 105.56% | -37.32% | |||
| Normalized Diluted EPS | 30.96% | -6.57% | |||
| Average Basic Shares Outstanding | -0.09% | -0.49% | |||
| Average Diluted Shares Outstanding | -0.09% | -0.28% | |||
| Dividend Per Share | 0.00% | 15.38% | |||
| Payout Ratio | -0.51% | 0.84% | |||